As of 2026-07-12, the Relative Valuation of Werewolf Therapeutics Inc (HOWL) is (23.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.40 USD, the upside of Werewolf Therapeutics Inc based on Relative Valuation is -5845.5%.
The range of the Relative Valuation is (22.58) - (24.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 21.4x | 19.4x |
| Forward P/E multiples | 19.5x - 21.6x | 20.6x |
| Fair Price | (22.58) - (24.78) | (23.15) |
| Upside | -5701.9% - -6247.7% | -5845.5% |
| Date | P/E |
| 2026-07-07 | -0.30 |
| 2026-07-06 | -0.28 |
| 2026-07-02 | -0.29 |
| 2026-07-01 | -0.30 |
| 2026-06-30 | -0.31 |
| 2026-06-29 | -0.27 |
| 2026-06-26 | -0.28 |
| 2026-06-25 | -0.29 |
| 2026-06-24 | -0.32 |
| 2026-06-23 | -0.31 |
| 2026-06-22 | -0.32 |
| 2026-06-18 | -0.30 |
| 2026-06-17 | -0.30 |
| 2026-06-16 | -0.31 |
| 2026-06-15 | -0.34 |
| 2026-06-12 | -0.33 |
| 2026-06-11 | -0.34 |
| 2026-06-10 | -0.32 |
| 2026-06-09 | -0.32 |
| 2026-06-08 | -0.33 |
| 2026-06-05 | -0.34 |
| 2026-06-04 | -0.37 |
| 2026-06-03 | -0.36 |
| 2026-06-02 | -0.37 |
| 2026-06-01 | -0.40 |
| 2026-05-29 | -0.39 |
| 2026-05-28 | -0.39 |
| 2026-05-27 | -0.42 |
| 2026-05-26 | -0.40 |
| 2026-05-22 | -0.38 |
| 2026-05-21 | -0.36 |
| 2026-05-20 | -0.38 |
| 2026-05-19 | -0.37 |
| 2026-05-18 | -0.43 |
| 2026-05-15 | -0.44 |
| 2026-05-14 | -0.47 |
| 2026-05-13 | -0.50 |
| 2026-05-12 | -0.55 |
| 2026-05-11 | -0.57 |
| 2026-05-08 | -0.59 |
| 2026-05-07 | -0.54 |
| 2026-05-06 | -0.56 |
| 2026-05-05 | -0.58 |
| 2026-05-04 | -0.60 |
| 2026-05-01 | -0.62 |
| 2026-04-30 | -0.62 |
| 2026-04-29 | -0.59 |
| 2026-04-28 | -0.64 |
| 2026-04-27 | -0.72 |
| 2026-04-24 | -0.70 |